These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 9562350
21. Islet allotransplantation in type I diabetic patients: effects of islet cell number on clinical outcome. Secchi A, Socci C, Maffi P, Falqui L, Bertuzzi F, De Nittis P, Piemonti L, Taglietti MV, Di Carlo V, Pozza G. Transplant Proc; 1996 Oct; 28(5):2861-5. PubMed ID: 8908102 [No Abstract] [Full Text] [Related]
22. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Roelen DL, Huurman VA, Hilbrands R, Gillard P, Duinkerken G, van der Meer-Prins PW, Versteeg-van der Voort Maarschalk MF, Mathieu C, Keymeulen B, Pipeleers DG, Roep BO, Claas FH. Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445 [Abstract] [Full Text] [Related]
31. Long-term metabolic control by rat islet grafts depends on the composition of the implant. Keymeulen B, Korbutt G, De Paepe M, Gorus F, Klöppel G, Pipeleers DG. Diabetes; 1996 Dec; 45(12):1814-21. PubMed ID: 8922370 [Abstract] [Full Text] [Related]
38. Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes Patients. Lee D, Gillard P, Hilbrands R, Ling Z, Van de Velde U, Jacobs-Tulleneers-Thevissen D, Maleux G, Lapauw B, Crenier L, De Block C, Mathieu C, Pipeleers D, Keymeulen B. Transplantation; 2020 Oct; 104(10):e295-e302. PubMed ID: 32433237 [Abstract] [Full Text] [Related]